Aquatic Capital Management’s Akero Therapeutics AKRO Stock Holding History

Aquatic Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-76,568	Closed	-$3.64M	–	1375
2025 Q3	$3.64M	Buy	76,568 +27,175	+55%	+$1.32M	0.07%	343
2025 Q2	$2.64M	Sell	49,393 -23,381	-32%	-$1.06M	0.05%	402
2025 Q1	$2.95M	Buy	72,774 +54,733	+303%	+$2.32M	0.08%	327
2024 Q4	$502K	Buy	18,041 +14,841	+464%	+$449K	0.01%	717
2024 Q3	$91.8K	Buy	+3,200	New	+$83.4K	﹤0.01%	935
2024 Q2	–	Sell	-19,800	Closed	-$500K	–	1181
2024 Q1	$500K	Buy	+19,800	New	+$476K	0.02%	544
2022 Q4	–	Sell	-1,000	Closed	-$34K	–	1321
2022 Q3	$34K	Buy	1,000 +100	+11%	+$1.53K	﹤0.01%	937
2022 Q2	$9K	Buy	900 +300	+50%	+$3.13K	﹤0.01%	979
2022 Q1	$9K	Buy	+600	New	+$10.5K	0.01%	678

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aquatic Capital Management's AKRO Position: Q4 2025 in Review

Aquatic Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 76,568 shares — an estimated $3.64M sold.

Aquatic Capital Management first reported a position in AKRO in Q1 2022 and held it in 9 quarters. The position peaked at $3.64M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Aquatic Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 76,568 Akero Therapeutics shares in Q4 2025, an estimated $3.64M.
Aquatic Capital Management first reported a position in Akero Therapeutics in Q1 2022 and held it in 9 quarters.
Aquatic Capital Management's Akero Therapeutics position peaked at $3.64M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.